Previous close | 1.0000 |
Open | 1.0000 |
Bid | 0.0000 |
Ask | 0.0000 |
Strike | 25.00 |
Expiry date | 2024-05-17 |
Day's range | 1.0000 - 1.0000 |
Contract range | N/A |
Volume | |
Open interest | N/A |
FOSTER CITY, Calif., May 10, 2024--Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Comprehensive Analysis of Mirum Pharmaceuticals' First Quarter Financial Performance and Future Outlook
Mirum's (MIRM) earnings and revenues miss estimates in the first quarter of 2024. Livmarli drives year-over-year sales.